Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Antag Therapeutics ApS
APS
Active
Advertising protection
CVR 38402056
Ole Maaløes Vej 3, 2200
København N
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2017 · 9 years old
10 employees
http://www.antagtherapeutics.com/
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
Antag Therapeutics ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
-3M
-6M
-9M
-12M
-13M
2021
-10M
2022
-14M
2023
-31M
2024
-192M
2025
EBITDA
DKK millions
0M
-65M
-129M
-194M
-259M
-16M
2021
-11M
+31%
2022
-16M
-45%
2023
-33M
-106%
2024
-207M
-527%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Gross profit
-13.086
-9.904
-13.708
-30.596
-191.588
Staff expenses
-2.652
-1.502
-2.291
-2.742
-15.300
EBITDA
-15.738
-11.406
-15.999
-33.339
-206.888
Depreciation & amort.
-34
-34
-33
-13
-0
EBIT
-15.772
-11.440
-16.032
-33.352
-206.888
Net financials
-1.687
-558
-939
-4.054
389
Profit before tax
-17.459
-11.997
-16.971
-37.405
-206.500
Tax
-2.595
-2.213
-3.160
-5.140
-5.500
Net profit
-14.863
-9.784
-13.811
-32.265
-201.000
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
20.671
17.564
23.970
225.361
28.033
Equity
10.858
4.639
-9.173
201.235
235
Long-term debt
8.671
9.106
28.276
4.690
1.784
Short-term debt
1.143
3.819
4.867
19.436
26.013
Total debt
9.813
12.925
33.143
24.126
27.797
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-20688816800.0%
This company
2021
2025
Equity ratio
0.8%
This company
38.2%
Market median
-98% vs market
2021
2025
Return on equity
-85419.1%
This company
18.4%
Market median
-464334% vs market
2021
2025
Net profit margin (of gross profit)
-20099958200.0%
This company
2021
2025
Asset turnover (of gross profit)
-6.83×
This company
2021
2025
Debt / equity
118.13×
This company
0.62×
Market median
-18953% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on Antag Therapeutics ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
